Saturday, Apr 27, 2024 | Last Update : 05:47 AM IST

JAMA Oncology

Exercise reduces risk of death among select cancer survivors

The study appears in the journal JAMA Oncology.

04 Jun 2018 5:15 PM

This drug ups risk of heart failure in cancer patients

The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma.

30 Dec 2017 6:45 PM

ADVERTISEMENT
ADVERTISEMENT